Nathan Bush, O'Melveny & Myers
China offers both opportunities and perils for US companies and investors. Official graft and commercial bribery remain pervasive, raising risks of liability under the US Foreign Corrupt Practices Act, other nations’ foreign bribery statutes like the new UK Bribery Act, and China's domestic law. Dozens of China-based companies listed on foreign stock exchanges are now facing regulatory investigations and shareholder litigation stemming from allegations of fraud and other misconduct. Are these symptoms of the same underlying weaknesses in China's corporate governance standards and opaque regulatory climate? Nate Bush will assess current efforts by US companies, investors, and regulators to confront these challenges, and the implications for China's political and economic climate.
Image
